Kiniksa Pharmaceuticals Ltd.
KNSA
|
|
| |
|
| Trading Volume | 6,761 |
|
|
21.74 - 14.37 |
| Market Cap Full | $ 1.3B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | 12.5% | -28.2% | -15.6% |
| Q2 | - | -4.9% | 30.9% | -2.5% |
| Q3 | - | - | 23.4% | 32.5% |
| Q4 | - | - | 3.8% | 16.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 0.5 | 19.9 | -6.7 | -5.1 | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| -3.5 | -11.1 | -16.3 | -0.1 | 28.9 | 1.6 | 33.8 | -8.6 | 0.8 | -12.2 | 6 | 8.5 |
| 2022 | |||||||||||
| -4.6 | -8.2 | -3.6 | -6.1 | -17.9 | 26.5 | 2.3 | 18.3 | 9.6 | -11.1 | 47.4 | -11 |
| 2021 | |||||||||||
| 9.4 | 8.9 | -10 | -11.1 | -15.8 | 0.5 | 10.1 | -17.9 | -9.5 | -6.5 | 9.1 | 1.3 |
| 2020 | |||||||||||
| 30.7 | 27.5 | -15.4 | 28.9 | 4.6 | 22.1 | -23.4 | -9.5 | -14.9 | 4.2 | 19.2 | -7.5 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | -0.4 | -0.7 | -0.5 |
| Q2 | 0.2 | -0.3 | -0.6 | -0.7 |
| Q3 | -0.2 | 3.2 | -0.4 | -0.7 |
| Q4 | 0 | 0.1 | -0.5 | -0.8 |
| A | -0.17 | 2.6 | -2.3 | -2.6 |